Evidence map›Paper›PMID 37115761›Full record

ArticlePloS one2023

Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny.

Owen P Leiser, Deanna L Auberry, Erica Bakker, Will Chrisler, Kristin Engbrecht, Heather Engelmann, Sarah Fansler, Vincent Gerbasi, Joshua Hansen, Chelsea Hutchinson and 17 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 2 institutions in 1 country.

Owen P LeiserPacific Northwest National Laboratory, Chemical and Biological Signatures, Seattle, WA, United States of America.ORCID 0000-0003-1190-5596
Deanna L AuberryPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Erica BakkerPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Will ChrislerPacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Kristin EngbrechtPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Heather EngelmannPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Sarah FanslerPacific Northwest National Laboratory, Environmental Protection & Regulatory Programs, Richland, WA, United States of America.
Vincent GerbasiPacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Joshua HansenPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.ORCID 0000-0001-9237-2773
Chelsea HutchinsonPacific Northwest National Laboratory, Integrative Omics, Richland, WA, United States of America.
Janine HutchisonPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Mary J LancasterPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Kathleen LawrencePacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Angela MelvillePacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Jennifer MobberleyPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Isabelle O'BryonPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Kristie L OxfordPacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Tessa OxfordPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Shelby PhillipsPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Kabrena E RoddaPacific Northwest National Laboratory, Radiochemical Analysis, Richland, WA, United States of America.
James A SanfordPacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Athena SchepmoesPacific Northwest National Laboratory, Biological Systems Science, Richland, WA, United States of America.
Brian E StaleyInCyte Diagnostics, Richland, WA, United States of America.
Kelcey TerrellInCyte Diagnostics, Richland, WA, United States of America.
Kristin VictryPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Cynthia WarnerPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.
Kristin M OmbergPacific Northwest National Laboratory, Chemical and Biological Signatures, Richland, WA, United States of America.ORCID 0000-0002-3390-6445
Pacific Northwest National Laboratory · USIncyte (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2020, the Department of Energy established the National Virtual Biotechnology Laboratory (NVBL) to address key challenges associated with COVID-19. As part of that effort, Pacific Northwest National Laboratory (PNNL) established a capability to collect and analyze specimens from employees who self-reported symptoms consistent with the disease. During the spring and fall of 2021, 688 specimens were screened for SARS-CoV-2, with 64 (9.3%) testing positive using reverse-transcriptase quantitative PCR (RT-qPCR). Of these, 36 samples were released for research. All 36 positive samples released for research were sequenced and genotyped. Here, the relationship between patient age and viral load as measured by Ct values was measured and determined to be only weakly significant. Consensus sequences for each sample were placed into a global phylogeny and transmission dynamics were investigated, revealing that the closest relative for many samples was from outside of Washington state, indicating mixing of viral pools within geographic regions.

Indexed as

COVID-19SARS-CoV-2Clinical Laboratory TechniquesCOVID-19 TestingHumansPhylogenyRNA, ViralSpecimen HandlingWashingtonWorkplaceRNA, Viral

Identifiers

PMID37115761
PMCPMC10146508
OpenAlexW4367309407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.